Selecta Biosciences, Inc. - stock earnings
Stock symbol SELB is outdated, potentially delisted? Maybe it is available on other exchange?
SELB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | 5.9 million USD | 16.8 million USD |
| 2022Q3 | -7.9 million USD | 20.7 million USD |
| 2022Q2 | 8.6 million USD | 39.3 million USD |
| 2022Q1 | 28.8 million USD | 34.0 million USD |
| 2021Q4 | 12.2 million USD | 29.9 million USD |
| 2021Q3 | -17.9 million USD | 24.4 million USD |
| 2021Q2 | 4.6 million USD | 19.7 million USD |
| 2021Q1 | -24.6 million USD | 11.1 million USD |
| 2020Q4 | -15.4 million USD | 12.0 million USD |
| 2020Q3 | -9.7 million USD | 4.6 million USD |
| 2020Q2 | -24.1 million USD | ? USD |
SELB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 35.4 million USD | 110.8 million USD |
| 2021 | -25.7 million USD | 85.1 million USD |
| 2020 | -68.9 million USD | 16.6 million USD |
| 2019 | -55.4 million USD | 6.7 million USD |
| 2018 | -65.3 million USD | 903000 USD |
| 2017 | -65.3 million USD | 207000 USD |
SELB
Price: $0.88
52 week price:
Earnings Per Share: -0.15 USD
P/E Ratio: 10.41
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 668100
Ebitda: -14.2 millionMarket Capitalization: 153.4 million